Suchergebnisse

The market expects Herc Holdings (HRI) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Harmony Biosciences Holdings, Inc. (HRMY) and argenex SE (ARGX). But which of these two companies

The upcoming report from Hormel Foods (HRL) is expected to reveal quarterly earnings of $0.33 per share, indicating a decline of 5.7% compared to the year-ago period. Analysts forecast revenues of

Harmony Biosciences Holdings, Inc. (HRMY) closed the last trading session at $36.59, gaining 1.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Healthcare Realty Trust (HR) came out with quarterly funds from operations (FFO) of $0.4 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.4 per share a year ago

Herc Holdings (HRI) came out with quarterly earnings of $2.07 per share, beating the Zacks Consensus Estimate of $1.84 per share. This compares to earnings of $3.58 per share a year ago. These

Hormel Foods Corporation HRL moves into fiscal 2026 with a better line of sight into its earnings trajectory after a challenging close to fiscal 2025. Management expects transitional headwinds early

The market expects Harmony Biosciences Holdings, Inc. (HRMY) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This

Investors interested in Transportation - Equipment and Leasing stocks are likely familiar with Herc Holdings (HRI) and Westinghouse Air Brake Technologies (WAB). But which of these two companies is

Hormel Foods Corporation HRL continues to refine its business mix as part of efforts to strengthen profitability and adapt to evolving consumer demand. The company has entered into an agreement to

The market expects Harrow (HROW) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook

Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.38 per share, missing the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.85 per share a

A downtrend has been apparent in H&R Block (HRB) lately with too much selling pressure. The stock has declined 28.7% over the past four weeks. However, given the fact that it is now in oversold

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Hormel Foods Corporation HRL reported preliminary results for the first quarter of fiscal 2026, reflecting modest sales growth and stable earnings. The early figures suggest that the company is

For Immediate Release

Chicago, IL – February 19, 2026 – Stocks in this week’s article are Harmony Biosciences Holdings, Inc. HRMY, Tripadvisor, Inc. TRIP, The AES Corp. AES and Concentrix Corp. CNXC

Hormel Foods Corporation HRL is set to release first-quarter fiscal 2026 earnings on Feb. 26, before market open. The Zacks Consensus Estimate for earnings has remained unchanged in the past 30 days